Shasun Pharmaceuticals Ltd (SHAS.NS)

SHAS.NS on National Stock Exchange of India

74.65INR
23 May 2013
Price Change (% chg)

Rs-4.60 (-5.80%)
Prev Close
Rs80.30
Open
Rs78.85
Day's High
Rs79.25
Day's Low
Rs73.50
Volume
124,649
Avg. Vol
238,690
52-wk High
Rs185.60
52-wk Low
Rs60.40

SHAS.NS

Chart for SHAS.NS

About

Shasun Pharmaceuticals Limited (SPL) is a holding company. The Company’s principal areas of operation are manufacturing of active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients. The Company is also into product development and provides contract research and manufacturing services. As of... (more)

Overall

Beta: 1.51
Market Cap (Mil.): Rs4,487.44
Shares Outstanding (Mil.): 56.62
Dividend: 0.40
Yield (%): 3.03

Financials

  SHAS.NS Industry Sector
P/E (TTM): 4.31 35.19 35.42
EPS (TTM): 18.41 -- --
ROI: -- 19.50 18.86
ROE: -- 20.27 19.73
Search Stocks

Latest News about SHAS.NS

Shasun Pharmaceuticals falls on Vertex drug warning

Reuters Market Eye - Shasun Pharmaceuticals falls 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.

20 Dec 2012

MARKET EYE-Shasun Pharmaceuticals falls on Vertex drug warning

* Shasun Pharmaceuticals falls 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions. * Shasun has a long-term agreement with Vertex for supply of active pharmaceutical ingredient for the Hepatitis C drug. * "There would be incremental impact on Shasun as about 25 percent of FY13 profits were expected to come in from Incivek supply," said Surya Patra,

20 Dec 2012
» More SHAS.NS News

Earnings vs. Estimates

Search Stocks